On January 15, 2026, ATLMed.org hosted an exceptional session on prostate cancer biomarkers led by Dr. Bamidele A. Adesunloye, MD, MSc, FACP, Chief of Medical Oncology at City of Hope. His expert talk, “Prostate Cancer Biomarkers: From PSA to Precision Medicine,” provided invaluable insights into the progression of prostate cancer diagnostics, shifting from traditional PSA […]
Author Archives: Zeron Turlington
ATLMed News, Healthcare Challenges, Oral Cancer, Smokeless Tobacco
Smokeless Tobacco and Oral Cancer: A Global Perspective
22
Jan
Jan
Smokeless tobacco (ST) use is a leading, yet preventable, cause of oral cancer and related mortality worldwide. Although the health risks of ST are well established, its use continues to rise in many regions, particularly in low- and middle-income countries (LMICs). Addressing this growing public health challenge requires not only effective policy but also strong […]
19
Jan
Jan
Today, we celebrate Martin Luther King Jr. Day, a federal holiday observed on the third Monday of January, honoring a leader whose vision and courage reshaped the conscience of a nation. Dr. King served as the chief spokesperson for nonviolent activism during the Civil Rights Movement, leading efforts to dismantle racial discrimination in federal and […]
16
Jan
Jan
For much of the past decade, telehealth advocates have focused on payment parity—the principle that virtual visits should be reimbursed at the same rate as in-person care. During the COVID-19 public health emergency, payment parity played a critical role in rapidly expanding access to care, stabilizing physician practices, and normalizing virtual medicine. But as telehealth […]
ATLMed News, GLP-1 Drug, Healthcare Challenges, Medicaid, Medicare
Federal Agreements Announced to Lower GLP-1 Drug Prices and Expand Coverage in 2026
14
Jan
Jan
On November 6, 2025, the Trump administration announced new pricing and coverage agreements with Eli Lilly and Novo Nordisk for widely used glucagon-like peptide-1 (GLP-1) receptor agonists, including tirzepatide (Mounjaro®, Zepbound®) and semaglutide (Ozempic®, Wegovy®). These agreements aim to lower out-of-pocket costs for some patients and expand access under federal health programs beginning in 2026. […]
AI-enabled Care, ATLMed News, Healthcare Challenges
Bringing AI-Enabled Care to Rural America: From Bandwidth to Bedside
10
Dec
Dec
Rural communities across the United States continue to face deep, long-standing healthcare challenges: long travel distances to clinics, shortages of specialists, hospital closures, and limited access to timely, high-quality care. These barriers contribute to higher rates of chronic disease, later diagnoses, and poorer health outcomes for millions of rural residents. A recent perspective in the […]
ATLMed News, Heart Failure, Sleep-tracking devics, Smart Tech
When Your Smartwatch Becomes a Lifesaver: How Wearable Tech Helped Diagnose a Life-Threatening Heart Condition
10
Dec
Dec
In an era where technology meets everyday life, digital health tools are proving to be more than just convenient—they can be lifesaving. A recent case published in the New England Journal of Medicine (NEJM) highlights a powerful example: a 70-year-old man whose smartwatch and smart mattress sensor detected a dangerously slow heart rate, long before […]
ATLMed News, COVID-19 vaccination, Flu Vaccine, U.S. Food and Drug Administration
Former FDA Commissioners Warn That New Vaccine Policies Could Undermine Public Health Protections
10
Dec
Dec
A group of twelve former commissioners of the U.S. Food and Drug Administration (FDA)—spanning multiple administrations and political parties—has issued an unprecedented public warning about recent changes to the agency’s vaccine regulatory framework. Their commentary, published in the New England Journal of Medicine (NEJM), argues that these policy shifts threaten the longstanding scientific and regulatory […]
ATLMed News, Heritage Fund, Medical Students, Scholarships
Save the Date | Announcing the 2026 Heritage Fund Scholarship & Awards Gala
18
Nov
Nov
A Night of Excellence, Legacy, and Leadership in Atlanta’s Medical Community The Atlanta Medical Association is proud to announce the 2026 Heritage Fund Scholarship & Awards Gala, on Sat., Feb., 28, 2026. This elegant evening is dedicated to honoring excellence in medicine, supporting the next generation of healthcare leaders, and celebrating the legacy of physicians […]
ATLMed News, National Academies of Sciences, Engineering, and Medicine, U.S. children
Truly Prioritizing Child Health: The Missed Opportunities of the MAHA Commission
11
Nov
Nov
The Make America Healthy Again (MAHA) Commission has brought long-overdue national attention to the health and well-being of U.S. children — marking the first White House–level focus on child health since 1971. While this renewed interest is welcome, a closer review shows that the Commission’s strategy falls short of addressing the core conditions driving poor […]